4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride CAS 106261-49-8 Imatinib Mesylate Intermediate High Purity

Lus piav qhia luv luv:

4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid Dihydrochloride

CAS: 106261-49-8 Nr

Cov tsos mob: Dawb rau Yuav luag Dawb Hmoov rau Crystal

Purity: ≥98.0% (HPLC)

Intermediate ntawm Imatinib Mesylate (CAS: 220127-57-1) hauv kev kho mob Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph + CML)

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Chemical Properties:

Tshuaj npe 4-[(4-Methylpiperazin-1-yl)methyl] benzoic acid dihydrochloride
Synonyms Imatinib Mesylate Intermediate
CAS Nr 106261-49-8
CAT Number Qauv TSIS MUAJ: RF-PI229
Tshuag xwm txheej Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons
Molecular Formula C13H20Cl2N2O2
Molecular Luj 307.22 Nws
Melting Point 305.0 ~ 307.0 ℃
Solubility Soluble hauv dej
Hom Ruifu Tshuaj

Specifications:

Yam khoom Specifications
Qhov tshwm sim Dawb rau Yuav luag Dawb Hmoov rau Crystal
Purity / Analysis Method ≥98.0% (HPLC)
Poob rau ziab ≤0.50%
Residue ntawm ignition ≤0.50%
Tag nrho cov impurities ≤ 2.0%
Qhov siab tshaj plaws ib leeg impurity ≤ 1.0%
Test Standard Enterprise Standard
Kev siv Pharmaceutical Intermediate ntawm Imatinib Mesylate (CAS: 220127-57-1)

Pob & Cia:

Pob: Lub raj mis, Aluminium ntawv ci hnab, Cardboard nruas, 25kg / Nruas, los yog raws li tus neeg yuav tsum tau muaj.

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb, noo noo thiab kab tsuag.

Qhov zoo:

1

FAQ:

Daim ntawv thov:

Shanghai Ruifu Chemical Co., Ltd. yog cov chaw tsim khoom thiab cov chaw muag khoom ntawm 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride (CAS: 106261-49-8) nrog cov khoom zoo.Nwsyog ib qho nruab nrab feem ntau nyob rau hauv cov synthesis ntawm Imatinib Mesylate (CAS: 220127-57-1).Imatinib Mesylate yog ib qho tyrosine kinase inhibitor, tshwj xeeb tshaj yog rau BCR-ABL, ib qho tshuaj hauv qhov ncauj rau kev kho mob ntawm cov neeg laus nrog Philadelphia chromosome positive chronic myeloid leukemia (CML) nyob rau theem mob thiab qee hom mob lymphoblastic leukemia (ALL), nrawm. theem thiab mob ntev tom qab tsis ua haujlwm ntawm kev kho interferon.

Sau koj cov lus ntawm no thiab xa tuaj rau peb